Universal Ibogaine Inc (V:IBO) — Market Cap & Net Worth
Market Cap & Net Worth: Universal Ibogaine Inc (IBO)
Universal Ibogaine Inc (V:IBO) has a market capitalization of $1.13 Million (CA$1.56 Million) as of May 2, 2026. Listed on the V stock exchange, this Canada-based company holds position #30130 globally and #1575 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Universal Ibogaine Inc's stock price CA$0.01 by its total outstanding shares 312858516 (312.86 Million). Analyse Universal Ibogaine Inc (IBO) cash conversion ratio to see how efficiently the company converts income to cash.
Universal Ibogaine Inc Market Cap History: 2021 to 2026
Universal Ibogaine Inc's market capitalization history from 2021 to 2026. Data shows change from $28.29 Million to $1.13 Million (-53.03% CAGR).
Universal Ibogaine Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Universal Ibogaine Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.49x
Universal Ibogaine Inc's market cap is 0.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $3.39 Million | $1.07 Million | -$10.50 Million | 3.17x | N/A |
| 2023 | $1.13 Million | $1.03 Million | -$2.39 Million | 1.10x | N/A |
| 2024 | $1.13 Million | $2.33 Million | -$2.05 Million | 0.49x | N/A |
Competitor Companies of IBO by Market Capitalization
Companies near Universal Ibogaine Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Universal Ibogaine Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Universal Ibogaine Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, Universal Ibogaine Inc's market cap moved from $28.29 Million to $ 1.13 Million, with a yearly change of -53.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$1.13 Million | 0.00% |
| 2025 | CA$1.13 Million | 0.00% |
| 2024 | CA$1.13 Million | 0.00% |
| 2023 | CA$1.13 Million | -66.67% |
| 2022 | CA$3.39 Million | -88.00% |
| 2021 | CA$28.29 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Universal Ibogaine Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.13 Million USD |
| MoneyControl | $1.13 Million USD |
| MarketWatch | $1.13 Million USD |
| marketcap.company | $1.13 Million USD |
| Reuters | $1.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Universal Ibogaine Inc
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada.